Home › Trial NCT01393509
The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
- Trial IDNCT01393509
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorMemorial Sloan Kettering Cancer Center
- Enrollment47
- Start date2011-07-06
- ConditionsMetastatic Solid Tumor · Lymphoma · Myeloproliferative Neoplasms (MPN)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.